IP Library Granted Patent US 7,483,749
Granted Patent B2
US 7,483,749 · App. 11/091,554 · Granted Jan 27, 2009

Method of enhancing myogenesis by electrical stimulation

Assignee: Bioheart, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,483,749
App. No.
11/091,554
Granted
Jan 27, 2009
Kind
B2
Abstract

The present invention provides a method for enhancing regeneration of the myocardium. The method comprises the steps of applying electrical stimulation to an injury site in the myocardium. The method can be used in combination with implantation of myogenic cells into the injury site. The electrical stimulation may be applied before or after the implantation.

Claims (9)

1. A method of enhancing myogenesis in myocardium comprising the steps of:

identifying an injury site in the myocardium; and applying electrical stimulation to the site, wherein the application of the electrical stimulation causes myogenesis, wherein the electrical stimulation is provided as 30 pulses per second with a voltage of 3.5 mV, and successively alternating currents of 700 to 1500 picoamps for one minute, 200 picoamps for 10 seconds, and again with 700 to 1500 picoamps for one minute.

2. The method of claim 1 , wherein the electrical stimulation recruits stem cells to the injury site.

3. The method of claim 1 , wherein the direction of the current of the electrostimulation is periodically reversed.

4. The method of claim 1 , further comprising the step of implanting myogenic cells into the site of injury before or after application of electrical stimulation.

5. The method of claim 4 , wherein the myogenic cells are first electrostimulated in culture.

6. The method of claim 5 , wherein the cells are electrostimulated with 15 mV and a current of 500 picoamps at 70 pulses per minute.

7. The method of claim 5 , wherein the cells are plated on collagen coated substrates.

8. The method of claim 5 , wherein the cells are stretched 0.2 mms at 70 beats per minute.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2020
From: U.S. STEM CELL, INC.
To: LEONHARDT, HOWARD J
Reel/Frame 052335/0629 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2020
From: LEONHARDT, HOWARD J
To: CAL-X STARS BUSINESS ACCELERATOR, INC.
Reel/Frame 052335/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2020
From: NORTHSTAR BIOTECH GROUP, LLC
To: LEONHARDT, HOWARD J
Reel/Frame 052335/0670 →
MERGER AND CHANGE OF NAME Recorded Jul 31, 2018
From: BIOHEART, INC.; U.S. STEM CELL, INC.
To: U.S. STEM CELL INC.
Reel/Frame 047293/0341 →
SECURITY INTEREST Recorded May 10, 2016
From: BIOHEART, INC.
To: NORTHSTAR BIOTECH GROUP, LLC
Reel/Frame 038532/0023 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2007
From: LEONHARDT, HOWARD J
To: BIOHEART, INC.
Reel/Frame 019879/0014 →
Continuity (3)
Continuation 1017105100 · Jun 13, 2002
Provisional Application 6029791300 · Jun 13, 2001
Related Publication 20050171578A1 · Aug 4, 2005